WHO ICTRP trial
The effect of adding intravenous ketamine to Midazolam in reducing the need for…
IRCT20211013052753N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20211013052753N1 |
|---|---|
| Public title | The effect of adding intravenous ketamine to Midazolam in reducing the need for analgesia after spinal anesthesia in elective cesarean section |
| Scientific title | Investigating the effect of adding intravenous ketamine to Midazolam in reducing the need for analgesia after spinal anesthesia in elective cesarean section |
| Primary sponsor | Mashhad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | Fetal cesarean section. Delivery by caesarean section, unspecified;O82.9 |
| Interventions | Intervention 1: Intervention group: In this group, patients are injected with 0.5 mg/kg ketamine and 0.02 mg/kg midazolam in a 2ml syringe during cesarean section after umbilical cord clamping. Intervention 2: Control group: In this group… |
| Registration date | Nov 14, 2021 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: